We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Acupuncture to Prevent Postoperative Bowel Paralysis (Paralytic Ileus)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00065234
Recruitment Status : Terminated (Not available)
First Posted : July 22, 2003
Last Update Posted : March 28, 2017
Sponsor:
Information provided by:

Study Description
Brief Summary:
The purpose of this study is to determine if acupuncture is effective in preventing prolonged postoperative paralysis of the gastrointestinal tract among patients undergoing colostomy/ileostomy closure.

Condition or disease Intervention/treatment Phase
Ileus Neoplasms Procedure: Acupuncture Phase 2

Study Design

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 100 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single
Primary Purpose: Prevention
Official Title: Acupuncture to Prevent Postoperative Paralytic Ileus
Study Start Date : September 2003
Estimated Study Completion Date : May 2006


Arms and Interventions


Outcome Measures

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Previous surgical cancer treatment with ileostomy/colostomy, now scheduled for closure
  • Hospital admission must be same day as surgery

Exclusion Criteria:

  • Incapacitating disease
  • Concurrent herbal or laxative use
  • Use of Heparin or Coumadin
  • Upper or lower extremity deformities
  • Chronic constipation prior to cancer diagnosis
  • History of cerebrovascular accident or spinal cord injury
  • Chronic pain that has been treated with any form of major opioid or weak opioids (=/> 30mg/24 hours)
  • Pacemaker or metal implants
  • Concurrent alternative medicine/herbal use
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00065234


Locations
United States, Texas
MD Anderson Cancer Center
Houston, Texas, United States, 77030
Sponsors and Collaborators
National Center for Complementary and Integrative Health (NCCIH)
Investigators
Principal Investigator: Joseph S Chiang, MD M.D. Anderson Cancer Center
More Information

ClinicalTrials.gov Identifier: NCT00065234     History of Changes
Other Study ID Numbers: R21AT001065-01A1 ( U.S. NIH Grant/Contract )
ChiangJ
First Posted: July 22, 2003    Key Record Dates
Last Update Posted: March 28, 2017
Last Verified: March 2017

Keywords provided by National Center for Complementary and Integrative Health (NCCIH):
Colostomy
Ileostomy

Additional relevant MeSH terms:
Ileus
Intestinal Pseudo-Obstruction
Intestinal Obstruction
Intestinal Diseases
Gastrointestinal Diseases
Digestive System Diseases